Diabetes Clinical Trials in Phoenix

Showing 141-160 of 282 trials

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

NCT01119846

The purpose of this study is to see if GSK1292263 is safe and well-tolerated when administered to type 2 diabetics, and to get preliminary information about whether it may be effective in the treatment of type 2 diabetes.

Diabetes Mellitus, Type 2

GlaxoSmithKline100 participantsStarted Jun 2009

Phoenix, Arizona, United States • Chula Vista, California, United States • Miami, Florida, United States +4 more locations

COMPLETEDPHASE3< 1 mile

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

NCT02298192

This trial is conducted in Europe, North America and the United States of America. The aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S420 participantsStarted Nov 2014

Hamilton, Alabama, United States • Chandler, Arizona, United States • Glendale, Arizona, United States +81 more locations

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Diabetes Trials in Other Cities

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Study In People With Type 2 Diabetes

Molecular Regulation of Muscle Glucose Metabolism

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

Thiazolidinedione Intervention With Vitamin D Evaluation

Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Other Conditions in Phoenix